ImmunoCellular Therapeutics, Ltd.
(NYSE Amex Equities : IMUC)

( )
IMUC After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading IMUC News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.84%166.041.2%$746.09m
INCYIncyte Corporation
-1.64%138.971.7%$615.47m
GILDGilead Sciences, Inc.
-0.50%67.491.0%$591.26m
CELGCelgene Corporation
-0.12%123.221.0%$511.52m
BIIBBiogen Inc.
-0.89%275.411.3%$448.41m
REGNRegeneron Pharmaceuticals, Inc.
-1.12%365.022.1%$314.21m
ALXNAlexion Pharmaceuticals, Inc.
0.15%120.261.6%$206.10m
KITEKite Pharma, Inc.
-2.46%74.5018.8%$204.96m
TSROTESARO, Inc.
-1.39%153.6216.1%$174.99m
ESPREsperion Therapeutics, Inc.
3.56%40.4018.7%$170.36m
ILMNIllumina, Inc.
-0.06%167.693.7%$165.15m
AUPHAurinia Pharmaceuticals Inc.
-1.64%8.396.3%$146.33m
CLVSClovis Oncology, Inc.
2.01%68.5317.5%$144.30m
VRTXVertex Pharmaceuticals Incorporated
-1.10%89.052.2%$133.48m
GBTGlobal Blood Therapeutics Inc
1.45%38.5511.9%$106.01m

Company Profile

ImmunoCellular Therapeutics, Ltd. is a clinical-stage company, which engages in the development of immune-based therapies for the treatment of cancers. Its lead product candidate, ICT-107, is a dendritic cell-based immunotherapy targeting multiple tumor-associated antigens on glioblastoma stem cells. Its pipeline also includes ICT-121, a patient-specific, dendritic cell-based immunotherapy targeting the CD133 antigen on stem cells in recurrent glioblastoma; ICT-140, a patient-specific, dendritic cell-based immunotherapy targeting antigens on ovarian cancer stem cells; and the Stem-to-T-cell research program which engineers the patient's hematopoietic stem cells to generate antigen-specific cancer-killing T cells. The company was founded on January 31, 2006 and is headquartered in Calabasas, CA.